NeuroMetrix, Inc.
NURODelisted May 1, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001289850
NeuroMetrix, Inc. was delisted on May 1, 2025; its insiders filed their last Form 4 on May 5, 2025; 14 institutions reported holding it in 13F filings for Q1 2025, worth $599.9K in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in NeuroMetrix, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NURO is no longer listed, and 13F filings after Q1 2025 list far fewer holders. See Q1 2025
- Institutional holders
- 0
- −14 vs. Q1 2025
- Shares held
- 0
- −135.4K (−100.0%) vs. Q1 2025
- Total value
- $0
- −$599.9K (−100.0%) vs. Q1 2025
- New holders
- 0
- 0 more added
- Sold out
- 14
- 0 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NURO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 14 | $599.9K |
| Q4 2024 | 16 | $364.8K |
| Q3 2024 | 16 | $247.6K |
| Q2 2024 | 11 | $205.1K |
| Q1 2024 | 12 | $130.7K |
| Q4 2023 | 13 | $340.2K |
| Q3 2023 | 14 | $227.1K |
| Q2 2023 | 13 | $423.2K |
| Q1 2023 | 12 | $776.1K |
| Q4 2022 | 15 | $810.8K |
| Q3 2022 | 17 | $1.59M |
| Q2 2022 | 17 | $2.07M |
| Q1 2022 | 17 | $2.04M |
| Q4 2021 | 17 | $3.11M |
| Q3 2021 | 21 | $7.13M |
| Q2 2021 | 14 | $1.19M |
| Q1 2021 | 11 | $967.0K |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding NeuroMetrix, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −26,385−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,610−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −18,318−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −15,124−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −12,834−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,082−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −4,696−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,889−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −902−100.0% | Sold out |
| Accent Capital Management, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −220−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −11−100.0% | Sold out |